The effects of the addition of clonidine to diuretics on the mobilization of ascites in the short term (diuretic response and requirement of diuretics) and the long term (readmissions for tense ascites and requirement of diuretics) were examined in patients with cirrhosis and with increased sympathe
Hemodynamic effects of a clonidine-induced decrease in sympathetic tone in patients with cirrhosis
โ Scribed by Richard Moreau; Samuel S. Lee; Antoine Hadengue; Alain Braillon; Dr. Didier Lebrec
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 573 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
A decrease in plasma noradrenalin-a reflection of sympathetic nervous system activity-by clonidine, a centrally acting u2-agoni8t, could reduce the hyperdynamic circulation oherved in cirrhosis and may thereby decregse portal hypertension. Plasma noradrenaline oonceatration and plasma renin activity as well as systemic and splanchnic hemodynamics were measured in 12 patients with cirrhosis and ascites before and after erlminietration of either 150 pg of clonidine or placebo. Plasma noradrenaline concentration significantly decrefeed in all patients after clonidine administration, whereas plasma renin activity did not change significantly. There were statistically significant reductions of cardiac output (-17.4%), mean arterial pressure (-12.2%). hepatic venous pressure gradient (-19.7%) and assygos blood flow (-26.6%) after administration of clonidine. No significant correlation was found between the reduction of plasma noradrenaline concentration and chmnges in systemic or splanchnic hemodynamics. Heqiatic blood flow was not changed by clonidine. Placebo admidstration had no effect on any laboratory or c meaeurement. We conclude that the reduction in sympathetic nervous system activity by clonidine and the subsequent decrease in the hyperdynamic circulation -eats that sympathetic overactivity contributes to the circulatory derangements in patients with cirrhosis.
Sympathetic nervous system activity is thought to be augmented in patients with cirrhosis, but this is not completely established. Although the weight of evidence points in this direction, the literature is replete with conflicting studies: some have found normal (1, 2) or increased serum catecholamines with hyposensitivity to their effects (3). Baroreflexes may be preserved (4) or attenuated (5, 6), while membrane adrenergic receptors show variable responses (7; Lebrec, D., et al., Heputology 1985; 5972, Abstract). However, amidst this plethora of divergent results, some clinical observations are clear: patients with cirrhosis demonstrate a hyperkinetic circulation with increased cardiac output and decreased systemic vascular resistance (8, 9). Furthermore, direct
๐ SIMILAR VOLUMES
## Republic of China Wedged hepatic venous pressure, free hepatic venous pressure and cardiac index were measured before and 1 hr after i.v. administration as well as 1 month and 3 months after chronic oral administration of verapamil in 10 patients with HBsAg-positive cirrhosis. The gradient bet
The effects of dopamine on kidney function have not been elucidated in patients with cirrhosis. Moreover, although increased portal pressure has been observed with supradopaminergic doses of dopamine in these patients, the splanchnic hemodynamic effects of low doses of dopamine have not been previou